Back to search

Netherlands· NL-da15293bdedb

Scintimun, 1mg kit voor radiofarmaceutisch preparaat

A 99mtc-technetium-antigranulozyten antikörper product containing besilesomab, registered in Netherlands by Telix Innovations S.A.. The same ATC class is registered in 9 of our 19 countries.

ATC V09HA03

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedScintimun, 1mg kit voor radiofarmaceu…ATCV09HA03REGISTER NO.NL-da15293bdedbPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

99mtc-technetium-antigranulozyten antikörper is registered in 9 of 19 countries.

Countries holding a registration under ATC V09HA03 (99mtc-technetium-antigranulozyten antikörper), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose

99mtc-technetium-antigranulozyten antikörper · ATC V09HA03

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
BESILESOMAB
Manufacturer
Telix Innovations S.A.
Country
Netherlands (NL)
ATC code
V09HA03
ATC class
99mTc-Technetium-Antigranulozyten Antikörper
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/09/602

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

99mtc-technetium-antigranulozyten antikörper in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All 99mtc-technetium-antigranulozyten antikörper products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Scintimun
  • Liechtenstein · Scintimun
  • Norway · Scintimun

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ffb47b00-8258-443f-b709-4e5a0d1788a1
GET /v1/drugs/ffb47b00-8258-443f-b709-4e5a0d1788a1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kit voor radiofarmaceutisch preparaat",
  "route": "Intraveneus gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/scintimun-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Technetium (99m Tc) Antigranulocyte Antibody",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp103272",
  "excipients": [
    "1,1,3,3-PROPAANTETRAFOSFONAAT TETRANATRIUM 2-WATER",
    "DINATRIUMWATERSTOFFOSFAAT 0-WATER (E 339)",
    "NATRIUMDIWATERSTOFFOSFAAT 0-WATER (E 339)",
    "NATRIUMHYDROXIDE (E 524)",
    "SORBITOL (E 420)",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "TINDICHLORIDE 2-WATER (E 512)",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "BESILESOMAB"
  ],
  "leaflet_url": null,
  "authorised_at": "2010/01/11",
  "procedure_number": "EMEA/H/C/001045",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/09/602",
  "additional_monitoring": "N"
}

See everything about 99mtc-technetium-antigranulozyten antikörper.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.